These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2897480)

  • 1. [Mechanism of recurrence and relapse in peptic ulcer after drug therapy; gastric juice and gastric acid secretion].
    Nakaizumi A; Iishi H; Tatsuta M; Okuda S
    Nihon Rinsho; 1988 Jan; 46(1):102-6. PubMed ID: 2897480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological inhibition of gastric secretion and treatment of peptic ulcer].
    Konturek SJ
    Rev Esp Enferm Apar Dig; 1978 Apr; 53(1):65-82. PubMed ID: 26940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversies, dilemmas, and dialogues. Reduction of gastric acidity in the treatment of peptic ulcer disease: how low should we go?
    Peterson WL; Harford WV
    Am J Gastroenterol; 1991 Jun; 86(6):671-5. PubMed ID: 1674838
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy for preventing peptic ulcer recurrence.
    Sutherland JE
    Am Fam Physician; 1986 Nov; 34(5):141-4. PubMed ID: 2877559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H2-receptor antagonists.
    Keithley JK
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current viewpoints in the pathogenesis and therapy of peptic ulcer].
    Tytgat GN
    Ned Tijdschr Geneeskd; 1987 Oct; 131(41):1799-802. PubMed ID: 2890110
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
    Grebnev AL; Miagkova LP; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772
    [No Abstract]   [Full Text] [Related]  

  • 11. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various problems on refractory peptic ulcers; ulcers resistant to therapy with H2-receptor antagonists--therapeutic countermeasures].
    Itoh M
    Nihon Rinsho; 1988 Jan; 46(1):140-5. PubMed ID: 2897483
    [No Abstract]   [Full Text] [Related]  

  • 15. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
    Gabryelewicz A; Sarosiek J; Laszewicz W
    Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Famotidine--a new histamine H2 receptor blockader].
    Grigor'ev PIa; Isakov VA; Iakovenko EP; Davydov SM; Vasil'eva ZI
    Klin Med (Mosk); 1991 Apr; 69(4):23-8. PubMed ID: 1865643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Perspectives in the drug therapy of peptic ulcer].
    Kamada T; Sato N; Kawano S
    Nihon Rinsho; 1988 Jan; 46(1):7-11. PubMed ID: 2897487
    [No Abstract]   [Full Text] [Related]  

  • 20. Antacids in the treatment of peptic ulcer: are they obsolete?
    Anand AC
    Trop Gastroenterol; 1990; 11(1):25-9. PubMed ID: 1972600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.